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Objectives: To investigate whether female patients with predominant voiding symptom really have
objective voiding phase dysfunction.
Methods: Female patients with lower urinary tract symptoms who underwent video-urodynamic study
between January 2009 and December 2012 were recruited. All patients completed a 3-day frequency-
volume chart. Symptom severity was evaluated using International Prostate Symptom Score (IPSS),
Overactive Bladder Symptom Score (OABSS) and Urogenital Distress Inventory (UDI-6) questionnaires.
The patients with IPSS-voiding subscores greater than IPSS-storage subscores and their most bother
symptom are one of voiding symptom of IPSS were deﬁned as subjective voiding dysfunction group (SVD
group). The demographics, IPSS scores, OABSS scores, frequency-volume charts and urodynamic vari-
ables were compared between SVD and non-SVD groups.
Results: Of the 842 enrolled patients, 142 (16.9%) were classiﬁed into SVD group. Total IPSS and IPSS-
voiding subscores of SVD group were signiﬁcantly higher than those of non-SVD group. Conversely, IPSS-
storage subscores, OABSS and UDI-6 scores of SVD group were signiﬁcantly lower than those of non-SVD
group. The prevalence of urodynamic voiding phase dysfunction was 64.7% in SVD group, which was
signiﬁcantly higher than those of non-SVD group (37.8%, p < 0.01). SVD group showed more prevalent
bladder outlet obstruction (50.0% vs. 27.0%, p < 0.01). There were no signiﬁcant differences in the
prevalence of impaired detrusor contractility between SVD and non-SVD group. Detrusor overactivity
was more prevalent in non-SVD group (5.6% vs. 18.6%, p < 0.01).
Conclusions: Even though the female patients complain of predominant voiding symptoms, only two
thirds of them were identiﬁed having urodynamic voiding phase dysfunction. On the other hand, in
female patients whose predominant complaint are not voiding symptom, around one third of themwere
found to have urodynamic voiding phase dysfunction. This study clearly indicates that in females sub-
jective low urinary tract symptoms are not necessarily reliable.
Copyright © 2016, Taiwan Urological Association. Published by Elsevier Taiwan LLC. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction challenging. Kuo concluded that clinical symptoms alone are notThe prevalence of subjective voiding symptoms in women var-
ied from 14.9% to 61.7%.1e3 Of women aged over 40 years, 6% have
objective voiding dysfunction.3 The prevalence of objective voiding
dysfunction in women with subjective voiding symptoms is much
less investigated.1 Actually, in females with voiding dysfunction the
predictive value of voiding symptoms is rather low.4
Female voiding dysfunction might be related to detrusor un-
deractivity (DU) or/and bladder outlet obstruction (BOO). Voiding
and storage symptoms could coexist, which makes the diagnosisy, Taipei Veterans General
11217, Taiwan.
ociation. Published by Elsevier Ta
et al., Do female patients with
p://dx.doi.org/10.1016/j.urols.reliable in the differential diagnosis of lower urinary tract symp-
toms (LUTS) in women.5 Therefore, further evaluation by imaging
and urodynamics might be mandatory.
Nevertheless, urodynamic studies are invasive and expensive
procedures with limited availability. Patient weighting of severity
of LUTS might be a valuable alternative. In the present study, we
attempt to analyze whether female patients with predominant
voiding symptom really have objective voiding phase dysfunction.2. Materials and methods
We recruited female patients with LUTS who underwent video-
urodynamic study between January 2009 and December 2012. Alliwan LLC. This is an open access article under the CC BY-NC-ND license (http://









Age ± SD (years) 56.7 ± 14.2 57.4 ± 15.3 0.6
Hypertension (%) 15.1 17.3 0.7
Type 2 diabetes mellitus (%) 5.2 4.9 0.7
Coronary artery disease (%) 2 1.5 0.8
Cerebrovascular accident (%) 2 1.4 0.8
Menopause (%) 31.7 25.7 0.2
SVD ¼ subjective voiding dysfunction.
Table 2
Assessment of lower urinary tract symptoms.
SVD group Non-SVD group p value
Total IPSS 16.4 ± 8.5 14.3 ± 9.5 0.01
IPSS-voiding 9.7 ± 5.7 7.2 ± 5.5 <0.001
IPSS-storage 5.8 ± 3.3 7.6 ± 4.3 <0.001
OABSS 5.2 ± 3.3 6.8 ± 4.2 <0.001
UDI-6 8.0 ± 5.6 10.1 ± 5.7 <0.001
IPSS ¼ International Prostate Symptom Score; OABSS ¼ Overactive Bladder Symp-




SVD group Non-SVD group p value
Frequency per 24 h 7.4 ± 6.2 8.4 ± 7.6 <0.01
Nocturnal frequency 1.2 ± 1.6 2.3 ± 1.7 0.02
Urgency episodes 0.5 ± 1.3 1.0 ± 2.4 0.03
Urge urinary incontinence 0.5 ± 1.5 0.6 ± 1.7 0.15
Functional bladder capacity (mL) 396.6 ± 120.9 374.9 ± 128.2 0.10
SVD ¼ subjective voiding dysfunction.
Table 4
Urodynamic study ﬁndings.
SVD group Non-SVD group p value
First desire to void (min) 172.9 ± 4.9 143.1 ± 74.2 0.001
Cystometric capacity (ml) 297.5 ± 54.8 254.9 ± 12.8 <0.001
Free Qmean (mL/min) 9.7 ± 11.2 13.0 ± 3.4 <0.001
Free Qmax (mL/min) 11.9 ± 3.6 25.5 ± 2.6 <0.001
Post-void residual (mL) 75.6 ± 67.6 45.8 ± 72.9 0.55
Pdet at Qmax (cmH2O) 24.9 ± 21.9 23.3 ± 15.0 0.3
Pdet at Qmax ¼ detrusor pressure at maximum ﬂow; Qmean ¼ mean ﬂow rate;
Qmax ¼ maximum ﬂow rate; SVD ¼ subjective voiding dysfunction.
Table 5
The prevalence of differential etiologies of voiding phase dysfunction.
SVD group, n (%) Non-SVD group,
n (%)
p value
Voiding phase dysfunction 92 (64.7) 265 (37.8) <0.01
BOO 71 (50.0) 189 (27.0) <0.01
Dysfunctional voiding 49 (34.5) 144 (20.6) <0.01
Post-SUI surgery 20 (14.1) 33 (4.7) <0.01
Bladder neck obstruction 8 (5.6) 14 (2.0) 0.01
Cystocele 4 (2.8) 45 (6.4) 0.09
Detrusor underactivity 10 (7.0) 62 (8.8) 0.48
Acontractile detrusor 12 (8.4) 68 (9.7) 0.64
BOO ¼ bladder outlet obstruction; SUI ¼ stress urinary incontinence;
SVD ¼ subjective voiding dysfunction.
Table 6
The prevalence of lower urinary tract disorders other than voiding phase dysfuncti
SVD group, n (%)
BPS/IC 11 (7.7)
Stress urinary incontinence 29 (20.4)
Detrusor overactivity 8 (5.6)
BPS/IC ¼ bladder pain syndrome/interstitial cystitis; SVD ¼ subjective voiding dysf
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history. Patients with overt neurological disorders (e.g., spinal cord
pathology)were excluded. All patients completed a 3-day frequency-
volume chart documenting voided volume, incontinence and ur-
gency episodes, and daytime and nighttime urinary frequency.
Symptom severity was evaluated using International Prostate
Symptom Score (IPSS), Overactive Bladder Symptom Score (OABSS)
and Urogenital Distress Inventory (UDI-6) questionnaires. Patients
were also requested to identify the one most bothersome symptom
from IPSS. The IPSS questionnaires composed of urine storage-
related and micturition-related symptoms. A subtotal score for
Question 1 (incomplete emptying), Question 3 (intermittency),
Question 5 (weak stream), and Question 6 (straining) was desig-
nated as the voiding subscore. A subtotal score for Question 2
(frequency), Question 4 (urgency), and Question 7 (nocturia) was
designated as the storage subscore. The patients with IPSS-voiding
subscores greater than IPSS-storage subscores whose most both-
ersome symptom was one of voiding symptoms of IPSS were
deﬁned as subjective voiding dysfunction group (SVD group). The
other patients were deﬁned as non-SVD group.
Avideo-urodynamic studywas performedwith thepatient in the
sitting position. Abdominal pressure was measured using a 24F
rectal balloon catheter. Intravesical pressure was determined using
an 8F transurethral catheter. Filling cystometrography was per-
formed at a ﬁlling rate of 30 mL/min. Our deﬁnition of DU in uro-
dynamic study was maximum ﬂow rate (Qmax) < 12 mL/s and
detrusor pressure (Pdet) atmaximumﬂow (Pdet atQmax)<10 cmH2O.
Primary bladder neck obstruction was deﬁned as detrusor contrac-
tion of any magnitude with radiographic evidence of obstruction at
the bladder neck with relaxed striated sphincter. The diagnosis of
dysfunctional voiding was made on the basis of radiographic evi-
dence of obstruction at mid-urethra in the presence of a sustained
detrusor contraction and dys-synergic sphincter contraction in
neurologically normal individuals.
The demographics, IPSS scores, OABSS scores, frequency-volume
charts and urodynamic variables were compared between SVD and
non-SVD groups. Student t test and ANOVA were used for univar-
iate analysis, while ManneWhitney U test was applied for the
analysis of the questionnaires. A p value < 0.05 was deﬁned as
statistically signiﬁcant.3. Results
Of the 842 enrolled patients, 142 (16.9%) were classiﬁed into the
SVD group. All demographic variables, including age and comor-
bidities (hypertension, type 2 diabetes mellitus, coronary artery
disease, and cerebrovascular accident), were similar between SVD
and non-SVD groups (Table 1).
Total IPSS and IPSS-voiding subscores of the SVD group were
signiﬁcantly higher than those of the non-SVD group. Conversely,
IPSS-storage subscores, OABSS and UDI-6 scores of the SVD group
were signiﬁcantly lower than those of the non-SVD group (Table 2).
Parameters of frequency-volume charts showed that 24-hour
frequency, nocturnal frequency, and urgency episodes were
signiﬁcantly lower in the SVD group than those in the non-SVD
group (Table 3).on.
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pacity were signiﬁcantly larger in the SVD group. Catheter-free
mean and maximum uroﬂow rate was signiﬁcantly higher in the
non-SVD group (Table 4). The prevalence of differential etiologies of
voiding phase dysfunction is shown in Table 5.
A total of 356 female patients with LUTS were diagnosed as
urodynamic voiding phase dysfunction, including BOO and
impaired detrusor contractility (Table 6). The prevalence of voiding
phase dysfunctionwas 92/142 (64.7%) in the SVD group, which was
signiﬁcantly higher than that in the non-SVD group (264/700,
37.8%). As being the single diagnostic tool in predicting voiding
phase dysfunction in female patients with LUTS, the sensitivity and
speciﬁcity of SVD was 92/356 (25.8%) and 436/486 (89.7%),
respectively. Furthermore, the positive and negative prediction
values were 92/142 (64.8%) and 436/700 (62.3%), respectively.
The SVD group showed more prevalent BOO (50.0% vs. 27.0%),
including dysfunctional voiding, bladder neck obstruction, and
poststress urinary incontinence surgery. Nevertheless, there were
no signiﬁcant differences in the prevalence of impaired detrusor
contractility, including DU and acontractile detrusor between the
SVD group and the non-SVD group. It is important to note that
35.3% patients in the SVD group did not have objective voiding
phase dysfunction. These patients were clinically diagnosed as
nonulcer bladder pain syndrome/interstitial cystitis (BPS/IC) or
stress urinary incontinence (Table 6). Moreover, detrusor over-
activity was more prevalent in the non-SVD group.
4. Discussion
Our study revealed that the sensitivity and speciﬁcity of SVD for
detecting objective voiding phase dysfunction in female patients
with LUTS was 25.8% and 89.7%, respectively. Despite the poor
sensitivity, the speciﬁcity was fairly good. If female patients with
LUTS are not compatible with the criteria of SVD, we could almost
exclude the possibility of voiding dysfunction and prescribe anti-
muscarinic agents directly for LUTS. Hsiao et al6 utilized IPSS-
voiding to IPSS-storage subscore ratio (IPSS-V/S) to predict the
voiding dysfunction in female patients with LUTS. They reported
that IPSS-V/S of 1.33 had the best predictive value with a high
sensitivity (92.9%) and negative predictive value (97.4%). Moreover,
the speciﬁcity and positive predictive values were 62.6% and 36.9%,
respectively. Therefore, we might combine SVD and IPSS-V/S to
increase the diagnostic accuracy of objective voiding dysfunction in
female patients with LUTS.
In the present study, BOO was more prevalent than underactive
bladder in female patients with predominant voiding symptoms.
Choi et al7 reported that 87.2% of a total of 102 female patients with
voiding dysfunction were diagnosed as BOO, while 12.8% patients
showed DU. Conversely, two large-scale retrospective studies8,9
have demonstrated the prevalence of BOO was quite low (0.15%
and 2.7% separately) in female patients with voiding symptoms,
and concluded that voiding dysfunction inwomenwas the result of
detrusor underactivity rather than BOO. Asnat et al10 reviewed 127
women with subjective voiding difﬁculty and found the diagnosis
of voiding dysfunction were proved in only one ﬁfth of these pa-
tients and was usually (96.3%) due to impaired detrusor contrac-
tility. Different diagnostic criteria for BOO and DU may play
important roles in the discrepancy. In the study of Choi et al,7 BOO
was deﬁned as Qmax < 15 mL/s and Pdet at Qmax > 20 cmH2O, while
detrusor underactivity was deﬁned as Qmax < 15 mL/s and Pdet at
Qmax < 20 cmH2O. Groutz et al10 deﬁned BOO as Qmax <12mL/s, Pdet
at Qmax > 50 cmH2O and the residual volume > 150 mL. Obviously,
Groutz's deﬁnition of BOO was stricter than Choi's.
In our study, the SVD group showed more prevalent BOO but
there was no difference in the prevalence of impaired detrusorPlease cite this article in press as: Chang Y-C, et al., Do female patients with
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seems that lower urinary tract symptoms are not useful informa-
tion for prediction of impaired detrusor contractility. Smith et al11
suggested that the symptom complex of underactive bladder is
not a reliable predictor of the urodynamic observation of DU.
Additionally, our deﬁnition of DU might also elucidate the poor
prediction of symptoms for DU. The ICS (2002) deﬁnes DU quali-
tatively as “a contraction of reduced strength and/or duration in
prolonged bladder emptying, and/or failure to achieve complete
bladder emptying within a normal time span.”12 Nevertheless, DU
was deﬁned quantitatively in our study.
The present study noted that 35.3% patients in SVD group did
not have objective voiding phase dysfunction. Mostly, these pa-
tients were clinically diagnosed as BPS/IC or stress urinary incon-
tinence. Hubeaux et al13 stated that 61% of female patients with
stress urinary incontinence complained of voiding symptoms. In
these patients, only 32% had an abnormal uroﬂowmetry. There was
poor correlation between subjective voiding symptoms and
objective voiding dysfunction in female patients with stress urinary
incontinence. BPS/IC is a syndrome characterized by storage
symptoms (urgency and frequency) and pelvic pain. Obstructive
symptoms such as slow stream, dribbling, and straining are often
reported by BPS/IC patients. Contrary to the present study, Cameron
et al14 reported that 48% of BPS/IC patients met criteria for BOO
which was deﬁned as Qmax < 12mL/s and Pdet at Qmax > 25 cm H2O.
Of these women, 55.2% had the ulcer BPS/IC. Diverse deﬁnitions of
BOO and BPS/IC types might responsible for the inconsistency.
UDI-6 assesses symptom distress and the impact on daily life of
lower urinary tract symptoms. UDI-6 scores of the non-SVD group
were signiﬁcantly higher than those of the SVD group. In addition,
IPSS-storage subscores and OABSS of the non-SVD group were
signiﬁcantly higher than those of the SVD group. The results sug-
gested that storage symptoms have a greater overall impact on
quality of life than voiding symptoms. Agarwal et al15 found that
both men and women with urgency urinary incontinence report
moderate or major bother more frequently than individuals with
other LUTS. At the population level, the most prevalent bothersome
symptoms are urgency, stress urinary incontinence, and nocturia.
5. Conclusions
Even though female patients complain of predominant voiding
symptoms, only two thirds of them were identiﬁed having urody-
namic voiding-phase dysfunction. On the other hand, in female
patients whose predominant complaints are not voiding symp-
toms, around one third of them were found to have urodynamic
voiding-phase dysfunction. This study clearly indicates that in fe-
males subjective low urinary tract symptoms are not necessarily
reliable.
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